From: MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
Cancers | Targeted gene products†| References |
---|---|---|
Cancers with down-regulation of miR-433-3p | ||
 | Acting as oncogenes or tumor promoters | |
CRC | CREB1, HOXA1, MACC1, MAPK8 | |
GC | KRAS | Guo et al. (2013) |
ESCC | REV3L | Li and Li (2021) |
OSCC | HDAC6, PAK4, PTK2 | |
NSCLC | E2F3, LPCAT1, SMAD2, NUCKS1 | Liu et al. (2018); Guo et al. (2022); Li et al. (2019a); Yu et al. (2022) |
BLCA | CREB1 | Xu et al. (2016b) |
HCC | CREB1 | Yang et al. (2013) |
PDAC | GOT1 | Zhou et al. (2021b) |
CeCa | TYMS, MTDH | |
 | Acting both as oncogenes and tumor suppressors, or unclassified | |
CRC | CCAR1 | Yan et al. (2018) |
GC | ATG5, ATG12 | Wang et al. (2021c) |
ESCC | HMGB1 | Cheng et al. (2020b) |
NSCLC | TIPRL | Zhang et al. (2021) |
BLCA | CCAR1 | Wang et al. (2020b) |
HCC | CBX3, FXYD3 | |
OVCA | NOTCH1 | Liang et al. (2016) |